Società Capricor Therapeutics Inc OTC Bulletin Board
Azioni
CAPR
US14070B1017
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Transformative Cell and Exosome-based Therapeutics
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 20/11/13 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 20/11/13 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Karen Krasney
LAW | General Counsel | 71 | 01/01/12 |
General Counsel | 71 | 28/02/15 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 21/07/23 |
Earl Collier
BRD | Director/Board Member | 76 | 20/11/13 |
George Dunbar
BRD | Director/Board Member | 77 | 20/11/13 |
David Musket
BRD | Director/Board Member | 66 | 20/11/13 |
Frank Litvack
CHM | Chairman | 68 | 01/01/12 |
Karimah Es Sabar
BRD | Director/Board Member | 66 | 23/07/21 |
Linda Marbán
CEO | Chief Executive Officer | 60 | 20/11/13 |
Paul Auwaerter
BRD | Director/Board Member | 62 | 13/07/23 |
Michael Kelliher
BRD | Director/Board Member | 47 | 01/09/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 31 811 470 | 29 183 127 ( 91,74 %) | 0 | 91,74 % |
Coordinate società
Capricor Therapeutics, Inc.
10865 Road to the Cure Suite 150
92121, San Diego
+858 727 1755
http://www.capricor.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,95% | 127 Mrd | |
+23,00% | 117 Mrd | |
+26,70% | 27,77 Mrd | |
-19,75% | 20,44 Mrd | |
-14,87% | 16,62 Mrd | |
-16,56% | 15,92 Mrd | |
+11,19% | 14,74 Mrd | |
-46,65% | 14,94 Mrd | |
+57,74% | 14,38 Mrd |